Page 397 - 16Neonatal Jaundice_compressed
P. 397

Appendix H: Evidence tables


 Bibliographic   Study Type &   Number of   Intervention & Comparison   Dichotomous outcomes   Continuous Outcomes
 Information   Evidence Level   Patients/Characteristics   (E:C)   (Mean:SD: N)
    RCT      Conventional Phototherapy   Group 1: 0/21   Group 1: Not reported
 Year:      Inclusion:      Group 2: 0/20   Group 2: Not reported
 2002   Blinding:      Group 2:
    Not reported   Exclusion:   Fiberoptic Phototherapy
 Country:                  Mean change in TSB:
 Italy   Randomisation:   Demographics:   Conventional phototherapy ( ‘Photo-  Group 1: -55 ± 16 micromol/litre
    Not report but sealed  Gender (M/F) : Not reported   Therapie 800’) consisted of a unit
 142
 ID:     envelopes used   Mean GA: 39.6 ± 1.2 weeks   incorporating a metal vapour discharge   Group 2: -51 ± 23 micromol/litre
    blue lamp with 2 filters (an infrared
 Evidence level:   Mean BW: 3236 ± 425 gms   filter and a Plexiglas ultraviolet filter).
 1 +   Age at entry to study   A fan was fitted to remove heat
     Not reported   generated by lamp.
 Mean TSB:
 296 ± 32 micromol/litre   Fiberoptic phototherapy (BiliBlanket
 PT) consisted of a 140W quartz halogen
 lamp with a built-in dichroic reflector
 with low infrared and ultraviolet
 radiation reflectivity. Light range was
 restricted to 400 – 550 nm.

 All babies were naked in a supine
 position at a stabilised room
 temperature.
 Author:   Methodology:   N: 136   Group 1:   ET:   Mean duration of phototherapy
 Romagnoli C   RCT      Conventional phototherapy   Group 1: 2/33   Group 1: 90.2 ± 24.3 hours
       Inclusion:      Group 2: 2/35
 Year:   Blinding:   TSB> 103 micromol/litre   Group 2:   Group 3: 1/35   Group 2: 92.1 ± 43.3 hours
 2006   No reported   GA < 30 weeks   Fiberoptic (Wallaby) phototherapy   Group 4: 0/33   Group 3: 94.4 ± 43.3 hours
       Exclusion:
 Country:   Randomisation:   Not reported   Group 3:   Erythema:   Group 4: 75.1 ± 23.6 hours
 Italy   Not reported but      Fiberoptic (BiliBlanket) phototherapy   Group 1: 10/33
    sealed envelopes used  Demographics:      Group 2: 9/35
 152
 ID:        Gender (M/F): 72/64   Group 4:   Group 3: 8/35   Max TSB::
 Evidence level:   Mean GA: 27.9 ± 1.4 weeks   Combined conventional and Fiberoptic  Group 4: 12/33   Group 1: 157 ± 43 micromol/litre
 1 +   (Wallaby) phototherapy
     Mean BW: 1019 ± 283 gms      Treatment failure:   Group 2: 169 ± 56 micromol/litre
 Age at entry to study   Conventional phototherapy consisted of  Group 1: 2/33   Group 3: 161 ± 44 micromol/litre
 38.3 ± 7.1 hours   standard phototherapy composed of 4   Group 2: 4/35   Group 4: 130 ± 22 micromol/litre
 Mean TSB: 109   fluorescent lamps and 4 blue lamps   Group 3: 1/35
        Group 4: 0/33
 40cm above the baby.
  ± 5 micromol/litre    Irradiance at skin level was
 2
 22 – 24 microW/cm /nm. Babies were
 naked except for eye patches and
 disposable diapers. Baby position was
 changed from prone to supine and vice
 versa every 6 hours.

 Fiberoptic Wallaby phototherapy

                                                                 271
   392   393   394   395   396   397   398   399   400   401   402